GRIN2A and depressive symptom measurement: In addition to these pathophysiological processes, GluN2A-containing NMDARs are also involved in disorder like depression (Han et al., 2015), epilepsy (Zhu et al., 2004), and schizophrenia (Miyamoto et al., 2001).